Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...

Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast-acting high-dose aspirin formulation: Estero, Florida Thursday, June 26, 2025, 18:00 Hrs [IST] ...

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at ...

With an initial forecast of USD 15,819.00 million in 2024, the sales revenue of polysilicon is vouching a considerable rise ...

C-FORWARD is the Second Phase 3 Trial in the Global HCV Development Program; the First Phase 3 Trial, C-BEYOND, is Currently Enrolling Patients in the US and Canada Regimen has Potential Best-in-Class ...

Prof Sir John Burn, from Newcastle University, said he would ask health regulators to formally advise a low dose of 75mg be ...

Here are the top tips on correctly identifying a heart attack and helping quickly during an emergency, according to ...

When large populations are studied, the people with blood pressures of 110/70 or less have the healthiest arteries—which ...

In 2022, the state relaxed its regulations on setting off fireworks on private property, allowing residents to ignite fireworks on certain holidays.

Two groups, according to antiplatelet drug, were studied: aspirin (250–500 mg single-dose) versus tirofiban (500 μg ... a lower risk of parenchymal hemorrhage (18 (17.4%) vs 4 (5.2%), aOR=0.27, 95% CI ...

Participants received continuous ASA treatment (100 mg/d; n = 78) or matching placebo (n = 77) for 12 days during the perioperative phase.